TELA Bio to Participate in the Gilmartin Group Emerging Growth Company Showcase
MALVERN, Pa., Sept. 18, 2023 (GLOBE NEWSWIRE) — TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage…
Year: 2023
ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
BAUDETTE, Minn., Sept. 18, 2023 (GLOBE NEWSWIRE) — ANI Pharmaceuticals, Inc. (ANI or the Company)…
Humacyte to Host In-Person KOL Event at the New York EDITION on September 20, 2023
DURHAM, N.C., Sept. 18, 2023 (GLOBE NEWSWIRE) — Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology…
Pfizer Invites Public to View and Listen to Webcast of October 31 Conference Call with Analysts
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and…
Mercury Introduces the First Space-qualified FPGA Processing Board Powered by AMD Xilinx Versal® Technology
Mercury’s SCFE6933 Mercury’s SCFE6933 is a radiation-tolerant, 6U SpaceVPX board that will make high-performance computing…
Enablence Announces New 4-Channel Course Wavelength Division Multiplexing (CWDM) Optical Demux Devices
Compact, Lower-Cost, Low Insertion Loss Transceivers Target Datacom Applications Fremont, California–(Newsfile Corp. – September 18,…
Sonim Hits Another Milestone: Tier-One Carrier in Australia Selects Premium Mobile Hotspot for 2024 Lineup
Sonim’s global momentum builds across mobile broadband San Diego, California–(Newsfile Corp. – September 18, 2023)…
Cognigy Recognized as a Customers’ Choice for Enterprise CAI Platforms in Gartner® Voice of the Customer Report
DÜSSELDORF, Germany & SAN FRANCISCO–(BUSINESS WIRE)–#cognigy—Cognigy, the leader in Conversational AI, has been recognized in…
Tom Rogers Appointed Executive Chairman of Oorbit Gaming and Entertainment
MENLO PARK, Calif.–(BUSINESS WIRE)–It was announced today that Tom Rogers was appointed Executive Chairman of…
Chemence Launches KURA-LOW™ Adhesive Technology Chemistry Platform Driving Paradigm Shift for Consumer Electronic Device Assembly Processes
ALPHARETTA, Ga.–(BUSINESS WIRE)–Chemence, Inc. Performance Materials research scientists are committed to solving next generation bonding…
Feinstein Institutes AI researchers receive $3.1M NIH grant to develop hospital risk and prevention tools
Study to help create new clinical support tools to monitor and predict outcomes of in-hospital…
Outsourcing Accelerates U.S. Firms’ Ongoing Payroll Progress
Companies still engaging service providers to add employee self-service, AI-based compliance and other features, ISG…
ShipLux Unveils Revolutionary Website Redesign, Streamlining User Experience and Enhancing Customer Interaction
Miami, Florida–(Newsfile Corp. – September 18, 2023) – ShipLux, a leading and revolutionary auto transport…
Avanade Appoints Karthik Narain, Accenture’s Group Chief Executive—Technology as Chair of its Board of Directors
SEATTLE–(BUSINESS WIRE)–Avanade, the leading Microsoft solutions provider, today announced that Karthik Narain, Accenture’s Group Chief…
AeroVironment, Inc. Completes Tomahawk Robotics Acquisition
ARLINGTON, Va.–(BUSINESS WIRE)–$AVAV #AeroVironment–AeroVironment has completed its acquisition of Tomahawk Robotics, a leader in AI-enabled…
Accenture Invests in Writer to Accelerate Enterprise Use of Generative AI
NEW YORK & SAN FRANCISCO–(BUSINESS WIRE)–Accenture (NYSE: ACN) has made a strategic investment, through Accenture…
New CrowdStrike Marketplace Transforms Cybersecurity Consumption with World-Class Security Ecosystem
New CrowdStrike Marketplace and CrowdCredit program incentivize CrowdStrike customers to discover, try and buy solutions…
AB Science provides an update on the EMA timetable for examination of the masitinib marketing authorization application in ALS
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE EUROPEAN MEDICINES AGENCY’S TIMETABLE FOR EXAMINATION…
Nextivity and Leviton Announce Business Alliance
New agreement delivers world-class cellular connectivity to enterprise customers SAN DIEGO–(BUSINESS WIRE)–Nextivity, the industry leader…
Lantern Pharma Receives IND Clearance from FDA Enabling Phase 1 Initiation for Drug Candidate LP-284 in Non-Hodgkin’s Lymphomas
This is the second IND Clearance over the last 100 days for drug candidates that…